51³Ô¹ÏÍø Medical Center has been selected by the  (ARPA-H) as an  of the , an initiative to address critical unmet challenges in women’s health, champion transformative innovations and tackle health conditions that uniquely or disproportionately affect women. VUMC will receive $3.3 million in funding over two years through the Sprint for Women’s Health spark track for early-stage research efforts.
, PhD, assistant professor of Pediatrics and Pharmacology, and , PhD, professor of Biomedical Engineering, joined forces four years ago to begin developing innovative uterine-targeted delivery systems for therapeutics known as tocolytics. These medications are designed to suppress premature uterine contractions during pregnancy.
“The collaborative environment among the faculty at VUMC and 51³Ô¹ÏÍø School of Engineering drives innovation and develops solutions to important, unmet medical needs,â€� Giorgio said. “The most interesting and successful research activities in my laboratory are generated from interdisciplinary collaborations.â€�
Every year, approximately 15 million pregnancies worldwide end prematurely, before 37 weeks of gestation. The United States has one of the highest rates of preterm births among high-resource countries, with 1 in every 10 women delivering prematurely. The estimated societal economic loss in the U.S. is approximately $25 billion, which includes medical costs, educational expenses and lost productivity.
Original article:Â